LRRK2 and Parkinson disease: In this study, we described that LRRK2 variants carriers had identical clinical features of idiopathic PD similar to previous reports (Alcalay et al., 2009; Gan‐Or et al., 2015; Liang et al., 2018; Pulkes et al., 2014).